Sunhawk Vision Biotech, Inc. · TPEX:7759

Sunhawk Vision Biotech, Inc. financial statements

Sunhawk Vision Biotech, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue00952.0K
Research and development151.3M76.1M87.0M12.1M34.6M
Selling, general and administrative24.0M25.0M26.0M
Operating income-175.4M-101.2M-113.1M-15.6M-39.6M
Depreciation and amortization5.75M4.74M1.33M30.0K30.0K
EBITDA-169.6M-96.4M-111.7M-15.5M-39.6M
Interest expense179.0K194.0K21.0K0
Income before tax-172.4M-87.1M-97.9M-15.2M-39.1M
Net income-172.4M-87.9M-25.1M-15.2M-39.1M
Earnings per share, basic-2.46-1.25-0.36-0.22-0.56

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents401.0M111.4M175.1M22.8M11.9M
Short-term investments91.4M53.5M38.0M23.0M
Current assets419.0M224.2M241.3M72.4M39.1M
Total assets498.8M308.8M320.8M142.5M109.2M
Current liabilities25.4M6.87M8.41M166.0K1.70M
Total liabilities27.0M12.6M11.3M166.0K1.70M
Shareholders' equity471.8M296.2M309.6M142.3M107.5M
Shares outstanding70.1M70.1M70.1M70.1M70.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-144.9M-95.0M-75.1M-24.1M-33.9M
Capital spending-415.0K-1.05M-3.32M00
Free cash flow-145.3M-96.1M-78.4M-24.1M-33.9M
Change in cash289.6M-63.7M128.3M10.9M2.14M